Facility gap analysis
New manufacturing facility gap analysis and existing manufacturing facility compliance assessment.
Risk-Based Gap Analysis Services
Sai Pharma Solutions Inc. identifies critical compliance gaps, prioritizes risks, and helps implement practical solutions for sustainable regulatory compliance, cGMP confidence, and operational excellence.
Comprehensive gap analysis across facilities, documentation, QMS, validation, technology transfer, training, computerized systems, data integrity, and inspection readiness.
New manufacturing facility gap analysis and existing manufacturing facility compliance assessment.
Documentation review, compliance gap analysis, and Quality Management System assessment.
Process validation, cleaning validation, technology transfer, and equipment compliance review.
Training system evaluation, computerized systems, data integrity, and regulatory inspection readiness.
Audit support is focused on what matters most: supplier qualification, customer readiness, regulatory inspections, laboratory controls, and CRO readiness for regulated submissions.
KSM/CRM, API, excipient, packaging material, contract manufacturing, and contract testing facilities.
Prepare teams, systems, documentation, and evidence for customer audit expectations.
Support inspection preparedness through risk review, gap closure, and readiness planning.
Review laboratory compliance, controls, documentation, and operational readiness.
Audit support for BA/BE study readiness related to ANDA and MAA registration pathways.
Findings are organized by risk and impact, so teams can focus on the gaps that matter most and close them with practical, science-based actions.
Identify compliance risks across systems, facilities, documentation, validation, and operations.
Prioritize critical gaps and assess root causes before corrective actions are defined.
Provide actionable recommendations, CAPA planning, effectiveness verification, and regulatory readiness support.
Gap analysis can be aligned with major pharmaceutical quality, regulatory, and data integrity expectations.
Gap analysis is useful only when it leads to practical decisions. Sai Pharma Solutions Inc. structures findings so leadership, quality teams, and operations can understand priority, ownership, and next steps.
Findings grouped by system, process area, risk level, and regulatory expectation.
Critical gaps highlighted first so resources are focused where compliance risk is highest.
Practical recommendations, CAPA planning, and effectiveness verification support.
Don't wait for an audit to discover your gaps. Discover them first, then close them with confidence.
Share your facility, system, validation, documentation, or audit readiness requirement to begin a focused compliance gap analysis conversation.